secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001213900-26-007330
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies 60 Degrees Pharmaceuticals of delisting for bid price rule violation
--------------------------------------------------------------------------------

- Nasdaq determined common stock failed $1.00 minimum bid price for 30 consecutive business days.
- Company ineligible for compliance period due to 1-for-5 reverse stock split on Feb 24, 2025.
- Warrants also subject to delisting under Nasdaq Listing Rule 5560(a).
- Company paid $20,000 hearing fee and appealed, staying suspension pending panel decision.
- No assurance the Nasdaq Panel will grant continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026007330/0001213900-26-007330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026007330/ea0273809-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-007330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer